BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25634008)

  • 21. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Significance of Solid and Micropapillary Components in Invasive Lung Adenocarcinomas Measuring ≤3 cm.
    Matsuoka Y; Yurugi Y; Takagi Y; Wakahara M; Kubouchi Y; Sakabe T; Haruki T; Araki K; Taniguchi Y; Nakamura H; Umekita Y
    Anticancer Res; 2016 Sep; 36(9):4923-30. PubMed ID: 27630350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
    Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
    J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
    Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.
    Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
    J Thorac Oncol; 2019 Feb; 14(2):245-254. PubMed ID: 30336325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current readings: pathology, prognosis, and lung cancer.
    Suh JH
    Semin Thorac Cardiovasc Surg; 2013; 25(1):14-21. PubMed ID: 23800525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
    Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
    J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study.
    Zombori T; Furák J; Nyári T; Cserni G; Tiszlavicz L
    J Clin Pathol; 2018 Feb; 71(2):135-140. PubMed ID: 28747392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.
    Westaway DD; Toon CW; Farzin M; Sioson L; Watson N; Brady PW; Marshman D; Mathur MM; Gill AJ
    Pathology; 2013 Oct; 45(6):553-8. PubMed ID: 24018816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
    Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
    Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cribriform pattern in lung invasive adenocarcinoma correlates with poor prognosis in a Chinese cohort.
    Qu Y; Lin H; Zhang C; Li K; Zhang H
    Pathol Res Pract; 2019 Feb; 215(2):347-353. PubMed ID: 30583815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
    Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
    J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cribriform growth pattern in lung adenocarcinoma: More aggressive and poorer prognosis than acinar growth pattern.
    Yang F; Dong Z; Shen Y; Shi J; Wu Y; Zhao Z; Jiang G; Song X
    Lung Cancer; 2020 Sep; 147():187-192. PubMed ID: 32721653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.
    Tsuta K; Kawago M; Inoue E; Yoshida A; Takahashi F; Sakurai H; Watanabe SI; Takeuchi M; Furuta K; Asamura H; Tsuda H
    Lung Cancer; 2013 Sep; 81(3):371-376. PubMed ID: 23891509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
    Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P
    Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth pattern-based grading of pulmonary adenocarcinoma-Analysis of 534 cases with comparison between observers and survival analysis.
    Boland JM; Wampfler JA; Yang P; Yi ES
    Lung Cancer; 2017 Jul; 109():14-20. PubMed ID: 28577944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
    Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
    J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.
    Lee G; Lee HY; Jeong JY; Han J; Cha MJ; Lee KS; Kim J; Shim YM
    Am J Surg Pathol; 2015 May; 39(5):660-6. PubMed ID: 25724001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.